Tyers Asset Management LLC bought a new stake in shares of Rite Aid (NYSE:RAD) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 302,632 shares of the company’s stock, valued at approximately $508,000.
Several other hedge funds and other institutional investors have also made changes to their positions in RAD. Sequoia Financial Advisors LLC purchased a new stake in Rite Aid in the 4th quarter worth about $101,000. Quantitative Systematic Strategies LLC purchased a new stake in Rite Aid in the 1st quarter worth about $134,000. Brave Asset Management Inc. raised its position in Rite Aid by 52.4% in the 4th quarter. Brave Asset Management Inc. now owns 80,000 shares of the company’s stock worth $158,000 after purchasing an additional 27,500 shares during the period. Parametrica Management Ltd purchased a new stake in Rite Aid in the 4th quarter worth about $182,000. Finally, Xact Kapitalforvaltning AB purchased a new stake in Rite Aid in the 4th quarter worth about $195,000. Hedge funds and other institutional investors own 50.37% of the company’s stock.
Rite Aid opened at $1.69 on Monday, Marketbeat.com reports. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.85 and a current ratio of 1.37. The stock has a market capitalization of $1.80 billion, a P/E ratio of -84.50 and a beta of 1.74. Rite Aid has a 1-year low of $1.38 and a 1-year high of $4.21.
A number of research firms recently weighed in on RAD. Mizuho reissued a “hold” rating on shares of Rite Aid in a research report on Tuesday, April 17th. Zacks Investment Research lowered shares of Rite Aid from a “buy” rating to a “hold” rating in a research report on Friday, April 13th. Finally, Vetr raised shares of Rite Aid from a “buy” rating to a “strong-buy” rating and set a $2.54 price objective on the stock in a research report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $2.33.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
Want to see what other hedge funds are holding RAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rite Aid (NYSE:RAD).
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.